an access intelligence company
Inform Educate Connect
PRA Advisors™
Offering high-end expertise to help innovative drug makers solve pricing, reimbursement, value, and access challenges in key global markets.
NRDL+
Our bi-weekly newsletter examines access policies and pathways for innovative medicines in China. We closely monitor the latest developments in these areas and engage in discussions with experts in China and around the globe.